Pharmacokinetics of isoflurane in human blood

Chih Cherng Lu, Chien Song Tsai, Oliver Yao Pu Hu, Ruei-Ming Chen, Ta-Liang Chen, Shung Tai Ho

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Investigation of isoflurane washout from the human body and brain provides more precise information about elimination in anesthesia. The elimination pattern of isoflurane remains poorly quantified, and therefore this study tried to clarify the pharmacokinetic pattern of isoflurane elimination. Sixteen patients (aged 48-78 years), undergoing coronary arterial bypass grafting surgery were enrolled in this study. Sixty minutes prior to the end of surgery, we kept a fixed 2% inspired isoflurane in 6,000 ml min-1 oxygen flow. Isoflurane supplement was then discontinued to study the 20-min isoflurane elimination. An infrared analyzer was used to determine both inspired isoflurane and end-tidal isoflurane. The isoflurane concentration in the internal jugular bulb blood, arterial blood and pulmonary arterial blood were analyzed by gas chromatography. Biexponential decay function was the best fitted for the end-tidal isoflurane- and arterial blood isoflurane-time curves. There were two distinct components, including initial 5-min fast component and the next 15-min slow component. Monoexponential decay function was the best fitted for the pulmonary arterial blood- and jugular bulb blood-time curves. During elimination, the initial washout of isoflurane from functional residual capacity of lungs is reflected in the fast component of the isoflurane concentration time curves. The later slow component is dominated by the tangible manifestation of physiological membrane barriers, including the existence of alveoli-pulmonary capillary, blood-brain barriers.

Original languageEnglish
Pages (from-to)344-349
Number of pages6
JournalPharmacology
Volume81
Issue number4
DOIs
Publication statusPublished - May 2008

Fingerprint

Isoflurane
Pharmacokinetics
Lung
Neck
Pulmonary Alveoli
Functional Residual Capacity
Blood-Brain Barrier
Human Body
Gas Chromatography
Anesthesia

Keywords

  • Anesthetic
  • Isoflurane elimination
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Lu, C. C., Tsai, C. S., Hu, O. Y. P., Chen, R-M., Chen, T-L., & Ho, S. T. (2008). Pharmacokinetics of isoflurane in human blood. Pharmacology, 81(4), 344-349. https://doi.org/10.1159/000122960

Pharmacokinetics of isoflurane in human blood. / Lu, Chih Cherng; Tsai, Chien Song; Hu, Oliver Yao Pu; Chen, Ruei-Ming; Chen, Ta-Liang; Ho, Shung Tai.

In: Pharmacology, Vol. 81, No. 4, 05.2008, p. 344-349.

Research output: Contribution to journalArticle

Lu, CC, Tsai, CS, Hu, OYP, Chen, R-M, Chen, T-L & Ho, ST 2008, 'Pharmacokinetics of isoflurane in human blood', Pharmacology, vol. 81, no. 4, pp. 344-349. https://doi.org/10.1159/000122960
Lu, Chih Cherng ; Tsai, Chien Song ; Hu, Oliver Yao Pu ; Chen, Ruei-Ming ; Chen, Ta-Liang ; Ho, Shung Tai. / Pharmacokinetics of isoflurane in human blood. In: Pharmacology. 2008 ; Vol. 81, No. 4. pp. 344-349.
@article{50984463956c4fc2960b16d349434a30,
title = "Pharmacokinetics of isoflurane in human blood",
abstract = "Investigation of isoflurane washout from the human body and brain provides more precise information about elimination in anesthesia. The elimination pattern of isoflurane remains poorly quantified, and therefore this study tried to clarify the pharmacokinetic pattern of isoflurane elimination. Sixteen patients (aged 48-78 years), undergoing coronary arterial bypass grafting surgery were enrolled in this study. Sixty minutes prior to the end of surgery, we kept a fixed 2{\%} inspired isoflurane in 6,000 ml min-1 oxygen flow. Isoflurane supplement was then discontinued to study the 20-min isoflurane elimination. An infrared analyzer was used to determine both inspired isoflurane and end-tidal isoflurane. The isoflurane concentration in the internal jugular bulb blood, arterial blood and pulmonary arterial blood were analyzed by gas chromatography. Biexponential decay function was the best fitted for the end-tidal isoflurane- and arterial blood isoflurane-time curves. There were two distinct components, including initial 5-min fast component and the next 15-min slow component. Monoexponential decay function was the best fitted for the pulmonary arterial blood- and jugular bulb blood-time curves. During elimination, the initial washout of isoflurane from functional residual capacity of lungs is reflected in the fast component of the isoflurane concentration time curves. The later slow component is dominated by the tangible manifestation of physiological membrane barriers, including the existence of alveoli-pulmonary capillary, blood-brain barriers.",
keywords = "Anesthetic, Isoflurane elimination, Pharmacokinetics",
author = "Lu, {Chih Cherng} and Tsai, {Chien Song} and Hu, {Oliver Yao Pu} and Ruei-Ming Chen and Ta-Liang Chen and Ho, {Shung Tai}",
year = "2008",
month = "5",
doi = "10.1159/000122960",
language = "English",
volume = "81",
pages = "344--349",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Pharmacokinetics of isoflurane in human blood

AU - Lu, Chih Cherng

AU - Tsai, Chien Song

AU - Hu, Oliver Yao Pu

AU - Chen, Ruei-Ming

AU - Chen, Ta-Liang

AU - Ho, Shung Tai

PY - 2008/5

Y1 - 2008/5

N2 - Investigation of isoflurane washout from the human body and brain provides more precise information about elimination in anesthesia. The elimination pattern of isoflurane remains poorly quantified, and therefore this study tried to clarify the pharmacokinetic pattern of isoflurane elimination. Sixteen patients (aged 48-78 years), undergoing coronary arterial bypass grafting surgery were enrolled in this study. Sixty minutes prior to the end of surgery, we kept a fixed 2% inspired isoflurane in 6,000 ml min-1 oxygen flow. Isoflurane supplement was then discontinued to study the 20-min isoflurane elimination. An infrared analyzer was used to determine both inspired isoflurane and end-tidal isoflurane. The isoflurane concentration in the internal jugular bulb blood, arterial blood and pulmonary arterial blood were analyzed by gas chromatography. Biexponential decay function was the best fitted for the end-tidal isoflurane- and arterial blood isoflurane-time curves. There were two distinct components, including initial 5-min fast component and the next 15-min slow component. Monoexponential decay function was the best fitted for the pulmonary arterial blood- and jugular bulb blood-time curves. During elimination, the initial washout of isoflurane from functional residual capacity of lungs is reflected in the fast component of the isoflurane concentration time curves. The later slow component is dominated by the tangible manifestation of physiological membrane barriers, including the existence of alveoli-pulmonary capillary, blood-brain barriers.

AB - Investigation of isoflurane washout from the human body and brain provides more precise information about elimination in anesthesia. The elimination pattern of isoflurane remains poorly quantified, and therefore this study tried to clarify the pharmacokinetic pattern of isoflurane elimination. Sixteen patients (aged 48-78 years), undergoing coronary arterial bypass grafting surgery were enrolled in this study. Sixty minutes prior to the end of surgery, we kept a fixed 2% inspired isoflurane in 6,000 ml min-1 oxygen flow. Isoflurane supplement was then discontinued to study the 20-min isoflurane elimination. An infrared analyzer was used to determine both inspired isoflurane and end-tidal isoflurane. The isoflurane concentration in the internal jugular bulb blood, arterial blood and pulmonary arterial blood were analyzed by gas chromatography. Biexponential decay function was the best fitted for the end-tidal isoflurane- and arterial blood isoflurane-time curves. There were two distinct components, including initial 5-min fast component and the next 15-min slow component. Monoexponential decay function was the best fitted for the pulmonary arterial blood- and jugular bulb blood-time curves. During elimination, the initial washout of isoflurane from functional residual capacity of lungs is reflected in the fast component of the isoflurane concentration time curves. The later slow component is dominated by the tangible manifestation of physiological membrane barriers, including the existence of alveoli-pulmonary capillary, blood-brain barriers.

KW - Anesthetic

KW - Isoflurane elimination

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=43449107968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449107968&partnerID=8YFLogxK

U2 - 10.1159/000122960

DO - 10.1159/000122960

M3 - Article

C2 - 18391509

AN - SCOPUS:43449107968

VL - 81

SP - 344

EP - 349

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 4

ER -